NCT00076440

Data

{
  "briefSummary": "ALADDIN is a research study to investigate the safety and effectiveness of leuprolide (a hormone drug) to improve the cognitive function and slow the progression of Alzheimer's disease (AD) in men 65 years and older with mild to moderate Alzheimer's disease who reside in the community.",
  "completionDate": "2007-03",
  "conditions": [
    "Alzheimer Disease"
  ],
  "enrollmentCount": 90,
  "enrollmentType": null,
  "nctId": "NCT00076440",
  "phase": "PHASE2",
  "sponsorId": "voyager-pharmaceutical-corporation",
  "startDate": "2003-12",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study",
  "url": "https://clinicaltrials.gov/study/NCT00076440"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version